G E Boeckxstaens1, A Smout. 1. Department of Gastroenterology and Hepatology, Academic Medical Centre, Amsterdam, The Netherlands. Guy.Boeckxstaens@med.kuleuven.be
Abstract
BACKGROUND: The importance of weakly acidic and weakly alkaline reflux in gastro-oesophageal reflux disease (GERD) is gaining recognition. AIM: To quantify the proportions of reflux episodes that are acidic (pH <4), weakly acidic (pH 4-7) and weakly alkaline (pH >7) in adult patients with GERD, and to evaluate their correlation with symptoms. METHODS: Studies were identified by systematic PubMed and Embase searches. Data are presented as sample-size weighted means and 95% confidence intervals. RESULTS: In patients with GERD taking a proton pump inhibitor (PPI), 80% (76-84%) of reflux episodes were weakly acidic or weakly alkaline and 83% (78-88%) of reflux symptom episodes were associated with weakly acidic or weakly alkaline reflux episodes. In patients with GERD not taking a PPI, 63% (59-67%) of reflux episodes were acidic and 72% (57-87%) of reflux symptom episodes were associated with acid reflux episodes. Six studies presented data separately for weakly alkaline reflux, which accounted for <5% of all reflux episodes, both on and off PPI therapy. CONCLUSIONS: Weakly acidic reflux underlies the majority of reflux episodes in patients with GERD on PPI therapy, and is the main cause of reflux symptoms occurring despite PPI therapy.
BACKGROUND: The importance of weakly acidic and weakly alkaline reflux in gastro-oesophageal reflux disease (GERD) is gaining recognition. AIM: To quantify the proportions of reflux episodes that are acidic (pH <4), weakly acidic (pH 4-7) and weakly alkaline (pH >7) in adult patients with GERD, and to evaluate their correlation with symptoms. METHODS: Studies were identified by systematic PubMed and Embase searches. Data are presented as sample-size weighted means and 95% confidence intervals. RESULTS: In patients with GERD taking a proton pump inhibitor (PPI), 80% (76-84%) of reflux episodes were weakly acidic or weakly alkaline and 83% (78-88%) of reflux symptom episodes were associated with weakly acidic or weakly alkaline reflux episodes. In patients with GERD not taking a PPI, 63% (59-67%) of reflux episodes were acidic and 72% (57-87%) of reflux symptom episodes were associated with acid reflux episodes. Six studies presented data separately for weakly alkaline reflux, which accounted for <5% of all reflux episodes, both on and off PPI therapy. CONCLUSIONS: Weakly acidic reflux underlies the majority of reflux episodes in patients with GERD on PPI therapy, and is the main cause of reflux symptoms occurring despite PPI therapy.
Authors: Xiaofang Huo; Stefanie Juergens; Xi Zhang; Davood Rezaei; Chunhua Yu; Eric D Strauch; Jian-Ying Wang; Edaire Cheng; Frank Meyer; David H Wang; Qiuyang Zhang; Stuart J Spechler; Rhonda F Souza Journal: Am J Physiol Gastrointest Liver Physiol Date: 2011-06-02 Impact factor: 4.052
Authors: Xiaofang Huo; Kerry B Dunbar; Xi Zhang; Qiuyang Zhang; Stuart Jon Spechler; Rhonda F Souza Journal: Am J Physiol Gastrointest Liver Physiol Date: 2020-01-27 Impact factor: 4.052
Authors: Xiaofang Huo; Agoston T Agoston; Kerry B Dunbar; Daisha J Cipher; Xi Zhang; Chunhua Yu; Edaire Cheng; Qiuyang Zhang; Thai H Pham; Uttam K Tambar; Richard K Bruick; David H Wang; Robert D Odze; Stuart J Spechler; Rhonda F Souza Journal: Gut Date: 2016-09-30 Impact factor: 23.059
Authors: Vikas Bhardwaj; Andela Horvat; Olga Korolkova; Mary K Washington; Wael El-Rifai; Sergey I Dikalov; Alexander I Zaika Journal: Carcinogenesis Date: 2016-09-21 Impact factor: 4.944